Cet appel ne nécessite pas de suivi particulier par le Département Recherche. Merci de suivre directement la procédure indiquée. Si toutefois vous souhaitez contacter le Département Recherche, écrivez à ulbkto@ulb.be (propriété intellectuelle) ou fonds.recherche@ulb.be (pour toute autre question).
INTER-LOCAL: international call for better local treatment of rare and/or hard to treat cancers
Kom op tegen Kanker
Five leading European cancer charities are joining forces in INTER-LOCAL, an international funding call aimed at accelerating clinical research into local treatment strategies for rare and hard-to-treat cancers. This initiative is a response to the urgent need for more effective and accessible therapies for patients facing limited treatment options.
The Swedish Cancer Society (Sweden), Norwegian Cancer Society (Norway), Scientific Foundation of the Spanish Association Against Cancer ( FCAECC; Spain), Stand up to Cancer (Kom op tegen Kanker; Belgium), and the Dutch Cancer Society (KWF; the Netherlands) are collaborating to stimulate cross-border clinical trials that focus on innovative local therapies in the domain of surgery and radiotherapy.
Why This Call Matters
Despite major advances in cancer treatment, survival rates for certain cancers remain alarmingly low. Rare cancers and hard-to-treat cancers often lack effective therapies, especially in advanced stages. Drug development alone has not sufficiently addressed these gaps, and local treatments - such as surgery and radiotherapy - offer promising alternatives that are often underfunded and underexplored.
Local therapies have evolved into highly precise interventions that can significantly improve patient outcomes and quality of life. However, their development faces limited financial incentives and fragmented research efforts. INTER-LOCAL aims to change that by fostering international collaboration and providing dedicated funding.
Financement
With a joint budget of €8.5 million, we seek to stimulate cross-border collaboration and support research with a clear impact on patient care, quality of life, and survival.
Pour postuler
You can submit your pre-proposal via the Grant Application System of the Swedish Cancer Society.
If you encounter technical problems or have questions about the Grant Application System, please contact forskning@cancerfonden.se.
All necessary documentation, guidelines, eligibility criteria, and application procedures are available on the INTER-LOCAL website: INTER-LOCAL: international call for better local treatment of rare and/or hard to treat cancers | KWF
For technical questions or issues about the Grant Application System:
For other questions, please contact the representative of your country:
SCS (SE) - Annina Graan
NCS (NO) - Marianne Aastebol Minge
FC AECC (ES) - Marina Reguero
KOTK (BE) - Mathieu Despeghel
KWF (NL) - Marte van den Heuvel
Requis d'admission
The INTER-LOCAL call supports late-phase (phase 2/3), international clinical trials focused on local treatment interventions for rare and/or hard-to-treat cancers. Eligible proposals must demonstrate:
A clear focus on rare cancers (incidence <6/100,000 / year) and/or hard-to-treat cancers with low survival rates (5-year-survival < 25%) .
Use of radiotherapy or surgery as the core experimental intervention.
A strong rationale for international collaboration, including patient recruitment, harmonization of protocols, and implementation of results.
Inclusion of partners from at least three of the five funding countries (Belgium, Netherlands, Spain, Norway, Sweden), with optional inclusion centers from other countries. Maximum collaboration between the funding countries will be taken into account during the evaluation of the clinical trial applications.
A robust plan for patient involvement, quality-of-life assessment, and long-term impact.
For additional details, please refer to the call documents on the website.
Zones géographiques
Les zones géographiques n'ont pas encore été spécifiées.